AC2-22678-68807
2 vaccinations
3 coded responses
25 check-ins
3 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 201 / VA
- Registered
- 2021-02-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-16
Registered in v-safe
-
2021-02-16
Dose 1 — Pfizer-BioNTech
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-02-19
- 2021-02-20
- 2021-02-21
- 2021-02-22
-
2021-02-25
Health check-in — day 7, dose 1Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-03-02
- 2021-03-09
-
2021-03-11
Dose 2 — Pfizer-BioNTech
-
2021-03-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Fatigue or tirednessAdult check-in
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-18
- 2021-03-25
- 2021-04-01
-
2021-04-08
Survey response — day 28, dose 2MedDRA: Asthma, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Environmental allergens. Severe Allergic asthma attacks. Mast Cell Activation Syndrome flareMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-08
Report sent to call center — day 28, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-15
-
2021-04-22
Survey response — day 42, dose 2MedDRA: Vertigo — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Severe tree pollen allergies. VertigoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-22
Report sent to call center — day 42, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-10
- 2021-09-09
-
2022-03-11
Survey response — 12 months, dose 2MedDRA: Anembryonic gestation, COVID-19 — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Blighted ovum conceived when I had CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-03-11
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-03-15
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-16 | Pfizer-BioNTech | |
| 2 | 2021-03-11 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-08 | Successful | Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
| 2021-04-22 | Successful | Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
| 2022-03-11 | Successful 2022-03-15 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 7 — day 28, dose 2
Symptoms: Environmental allergens. Severe Allergic asthma attacks. Mast Cell Activation Syndrome flare
Release 7 — day 42, dose 2
Symptoms: Severe tree pollen allergies. Vertigo
Release 11 — 12 months, dose 2
Symptoms: Blighted ovum conceived when I had Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anembryonic gestation | · | · | ✓ |
| SD | Asthma | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Vertigo | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release